French decree on cytogenetic testing:
This article was originally published in Clinica
Executive Summary
Prior authorisation from the government is needed for laboratories in France to perform cytogenetic testing antenatally or postnatally, including when they are being used as a means to determine the sex of a foetus or to determine whether an ultrasound follow-up is needed. That is the thrust of a decree published in the Journal officiel on November 30, which also sets out the levels at which these laboratories will be reimbursed for the tests. The decree also lays out the conditions under which reimbursement will be given.